Global market of dietary supplement is welcoming a rising star GLYMATE

Food and Healthcare Press Releases Monday August 19, 2019 08:00
BREA, California--19 Aug--PRNewswire/InfoQuest

Glymate(TM), a newly founded nutraceutical company in Southern California. Its proprietary sugar balance dietary supplement was officially announced in the United States in June 2019, marking the official launch of the global marketing of this product, which is available to consumers worldwide.

Glymate(TM) is an intense cellular regeneration dietary supplement that benefits the human body at multiple levels, and its patented key ingredient differentiates itself from other products. Our cellular regeneration technology promotes healthy insulin sensitivity and production which helps to break down glucose from food and transfer to energy*. When Glymate(TM) is consumed consistently, it helps our body energized and promotes bodyweight loss*. It is currently available through the company website and Amazon; we are also working with distributors for greater market access worldwide.

Today, there are more than 400 millions of people in the world are suffering from diabetes and the number of people who have high sugar blood level to prediabetes condition is much greater. "It's urgent that we take swift action to effectively treat and prevent this serious disease," a statement from the CDC reads. Glymate has dedicated years of research and numerous trials specifically to help the urgent needs of humans to address and prevent the seriousness of this problem. Glymate(TM) uses only all-natural ingredients, it is dairy-free, soy-free, gluten-free, wheat-free, no sugar, no preservatives and it's manufactured by Robinson in California. Its uniquely formulated soft gel with its proprietary patented regeneration technology is designed to help improve and balance blood sugar, cholesterol, and triglyceride levels by promoting healthy lipid metabolism*. It is carefully blended to increase the solubility and absorbency of the active ingredients. Glymate(TM)'s key ingredient affects the body at the molecular level and has a variety of functions inside cells*.

About Glymate(TM) Corp.

The Glymate(TM) Corp. is a privately held company, a global leader in health and wellness backed by a proven track record in its patented key ingredient. As a marketer and online seller of dietary supplements, we are committed to supporting consumers' wellness needs through high-quality product backed by science.

To learn more about Glymate(TM), please visit https://www.glymateusa.com. Follow Glymate(TM) on Instagram now at @glymate_usa.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Logo - https://mma.prnewswire.com/media/959709/Glymate_Logo.jpg

Latest Press Release

Califia Farms Completes Landmark $225 Million Financing with Diverse Group of Global Investors

Funding Provides Califia Farms, a leading plant-based food and beverage company, with long-term capital and global support for continued rapid expansion, and disruption of the $1 trillion+ dairy and ready-to-drink coffee markets Califia Farms(R), a...

Herbalife Nutrition Expert Shares Valuable Nutrition Tips to Make Smart Food Choices and Promote Healthy Eating Habits

Herbalife Nutrition (NYSE:HLF), a premier global nutrition company, recently invited Dr.Jonathan Yarom, Herbalife Nutrition Advisory Board Member, to share valuable health and nutrition information to its Independent Members in Thailand. Dr. Yarom has...

Jetts 24 Hour Fitness registers record-breaking growth in Asian fitness industry with opening of 22 clubs across Thailand in 24 months

Jetts 24 Hour Fitness, the fastest-growing fitness chain in Thailand, now has a total of 22 clubs up and running in the country in a testament to its philosophy of bringing exercise opportunities to people with the utmost ease of convenience. Thailand's...

12th Consecutive Year Leading United States in Organ Donation for Gift of Life Donor Program

Region Again Breaks Two U.S. Records, Showing Extraordinary Generosity and Clinical Leadership: Most Organ Donors and Life-Saving Transplants For the 12th consecutive year, Gift of Life Donor Program is the nation's leading organ procurement...

CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs

CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million Series E investment led by New Alliance Capital. The investment included participation...

Related Topics